Meribank Biotech Co., Ltd (4724.TWO)
Taipei Exchange · TWD · Healthcare · Biotechnology
NT$9.02 (+3.44%) as of
Key statistics
- Market cap
- 865.71M
- EPS (TTM)
- -1.43
- Dividend yield
- 0.00%
- 52-week range
- 7.94 – 19.05
- Beta
- 0.43
- Revenue (TTM)
- 408.48M
- Profit margin
- -33.07%
- Volume
- 31.27k
About Meribank Biotech Co., Ltd
Meribank Biotech Co., Ltd researches, develops, manufactures, and stores mesenchymal stem cells in Taiwan. The company engages in the detection, extraction, cryopreservation, archiving, and storage of umbilical cord blood, placental and umbilical cord mesenchymal stem cells, adult peripheral blood stem cells, and immune cells. It also provides cell cryopreservation services. The company was founded in 2001 and is based in Taipei, Taiwan.
- Sector
- Healthcare
- Industry
- Biotechnology
- Headquarters
- Taipei, Taiwan
Financial statements (income statement, balance sheet, cash flow) and an interactive price chart are available on this page with JavaScript enabled.